Compare Sinergi Inti Plastindo Tbk. (ESIP) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sinergi Inti Plastindo Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Sinergi Inti Plastindo Tbk. trades at Rp129 (market cap 142.07B, 8.47M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp147 (market cap 576.7B, 2.63M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 4.1× Sinergi Inti Plastindo Tbk.'s market cap, and Sinergi Inti Plastindo Tbk. is more actively traded (8.47M versus 2.63M). Which is the better fit depends on your goals.
| ESIP | LABS | |
|---|---|---|
Market Cap | 142.07B | 576.7B |
Volume | 8.47M | 2.63M |
Lot | 84.7K | 26.33K |
Turnover | 1.1B | 397.92M |
Average Price | 129.39 | 151.11 |
Value | 1.1B | 397.92M |
Indicative Equilibrium Price | 128 | 147 |
Indicative Equilibrium Volume | 193.3K | 311 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sinergi Inti Plastindo Tbk.
PT Sinergi Inti Plastindo Tbk (the”Company”) was established based on the notarial deed No.123 dated October 12, 2001 from Dr. Irawan Soerodjo, S.H., M.Si., Notary in Jakarta. PT Tanindo Omega Pasifik is a ultimate parent entity.
Read more on ESIP →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
